
INZY
Marshall Wace’s Inozyme Pharma INZY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $204K | Buy |
+50,900
| New | +$204K | ﹤0.01% | 2314 |
|
2023
Q4 | – | Sell |
-135,783
| Closed | -$570K | – | 2042 |
|
2023
Q3 | $570K | Buy |
135,783
+7,876
| +6% | +$33.1K | ﹤0.01% | 1404 |
|
2023
Q2 | $712K | Sell |
127,907
-67,190
| -34% | -$374K | ﹤0.01% | 1475 |
|
2023
Q1 | $1.12M | Buy |
+195,097
| New | +$1.12M | ﹤0.01% | 1378 |
|
2022
Q1 | – | Sell |
-36,033
| Closed | -$247K | – | 2929 |
|
2021
Q4 | $247K | Buy |
36,033
+2,625
| +8% | +$18K | ﹤0.01% | 2417 |
|
2021
Q3 | $387K | Sell |
33,408
-6,794
| -17% | -$78.7K | ﹤0.01% | 1967 |
|
2021
Q2 | $685K | Sell |
40,202
-11,611
| -22% | -$198K | ﹤0.01% | 1542 |
|
2021
Q1 | $1.03M | Buy |
+51,813
| New | +$1.03M | ﹤0.01% | 1383 |
|
2020
Q4 | – | Sell |
-12,418
| Closed | -$326K | – | 1881 |
|
2020
Q3 | $326K | Buy |
+12,418
| New | +$326K | ﹤0.01% | 1310 |
|